SEC Form 4 · accession 0001019687-16-006875
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey OBrien
Officer — Vice President
Period of report
Jul 5, 2016
Accepted (ET)
Jul 7, 2016 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 5, 2016 | M | 3,300 | $4.80 | A | 8,300 | D | |
| Common Stock | Jul 5, 2016 | S | 3,300 | $8.00 | D | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $4.80 | Jul 5, 2016 | M | 3,300 | D | — | Jul 6, 2019 | Common Stock | 3,300 | 21,700 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2The option vested over a period of 4 years in equal monthly installments from the 7/7/2009 date of grant and is now fully vested.